๐Ÿ›๐•ฃ๐•• ๐•ช๐•–๐•’๐•ฃ ๐•Ÿ๐• ๐•ฅ๐•–๐•ค ~๐Ÿ—’
457 subscribers
169 photos
62 files
2 links
ู…ู„ุฎุตุงุช ุณู†ุฉ ุซุงู„ุซุฉ ุจุดุฑูŠ~ ๐ŸŒธ
Download Telegram
Forwarded from ู†ู‚ุงุท ู…ู‡ู…ู‡ ู„ุดูŠุชุงุช ุงู„ุฌุงู…ุนุฉ3ุจุดุฑูŠ ุฏูุนุฉ 47 (Hind Al-Mismari)
ุฏุงูŠุฑุชู‡ู… ุทุงู„ุจุฉ ู…ู† ุฏูุนุฉ 45

ุถุฑูˆุฑูŠ ุฌุฏุง ุชุญู„ูˆ ูˆุชุฏุฑุจูˆ ุนู„ูŠ cases
ู†ุจุฏูˆุง ุจุงู„ 3) drugs used in heart failure๐Ÿ’ซ

ุงู„ุดูŠุช ูƒู„ุงู…ู‡ ูˆุงุฌุฏ ุจุณ ุชู„ู‚ูˆ ู…ุนุธู…ู‡ ู…ูƒุฑุฑ ูˆ ุฃู‡ู… ุฌุฒุฆูŠุฉ ู‡ูŠ digoxin
โค5
ู‚ุจู„ ู…ุง ู†ุจุฏูˆุง ููŠ ุงู„drugs ู„ุงุฒู… ู†ูู‡ู…ูˆุง ุงู„pathophysiology ู„ู„HF ูˆ ู‡ุฐุง ููŠุฏูŠูˆ ู„ููˆุฏู‡ ุชู„ู‚ูˆ ููŠู‡ ุงู„ุดุฑุญ~ โ˜๏ธ
๐Ÿ‘1
ุฃุญุชู…ุงู„ ูŠุฌู† ุฅูƒุณุจู„ุงูŠู† ุฃูˆ ุดูˆุฑุช ู†ูˆุช~

โ•list drugs used to reduce preload afterload and myocardial contractility in CHF vs AHF? โญ
โ–ซ๏ธCHF
(preload): loop - ACEI ARBs - nitrates
(after load): ACEI ARBs - hydralazine
(contractility): Digoxin

โ–ซ๏ธAHF
(preload): loop - nitrates - nitroprusside
(afterload): nitroprusside
(contractility): dopamine - dobutamine - inamrinone

โ•advantages of ACEI in HF? โญโญโญ
โ–ซ๏ธimprove exercise tolerance & congestive symptoms
โ–ซ๏ธdecrease mortality in HF
โ–ซ๏ธrenoprotective
โ–ซ๏ธdo not induce reflex tachycardia

โญโญโญโ•Explain advantages of ARBs?
โ–ซ๏ธno bradykinin production
โ–ซ๏ธantagonize Ag II formed by ACE
โ–ซ๏ธavoid hormonal escape
โ–ซ๏ธincrease activity of AT2 โ†’ โ†‘VD

โ•List precautions when using nitroprusside?
โ–ซ๏ธgive slow IV
โ–ซ๏ธfreshly prepared in saline with opaque foil
โ–ซ๏ธfrequent monitoring of BP
โ–ซ๏ธavoid prolonged administration to prevent cyanide toxicity

โญโ•Explain the beneficial effects of spironolactone in reducing mortality in HF?

โ•beneficial effects of beta bl. in reducing mortality in HF โญโญโญ
โ–ซ๏ธู†ุฒู„ู‡ ุณู„ุงูŠุฏ

โ•CI of digoxin? โญโญ

โ•Explain why digoxin CI with AF+WPW? โญ
โ–ซ๏ธb/c blocks AVN โ†’ โ†‘conduction in accessory tract

โ•Explain why digoxin CI with erythromycin?
โ–ซ๏ธb/c decrease inactivation of digitalis by killing GIT flora lead to increase absorption and toxicity

โ•Explain digitilization? โญโญโญ
(ู…ู‡ู… ู…ู‡ู… ุฌุฏุง ุงู„ุฏูƒุชูˆุฑุฉ ุนุงูˆุฏุชู‡ุง ูƒู… ู…ุฑุฉ)
โ–ซ๏ธto achieve therapeutic bl. lvl & to avoid toxicity
โ–ซ๏ธlow dose 0.125-0.25 mg/d (Css reached in one week)

โ•TTT of digitalis toxicity? โญโญ

โ•Order of therapy in CHF? โญ
๐Ÿ‘4
ุงู„ุณู„ุงูŠุฏุงุช ุงู„ู„ูŠ ู‚ุงู„ุช ุนู„ูŠู‡ุง ุงู„ุฏูƒุชูˆุฑุฉ ุงู† ู†ุฑูƒุฒูˆุง ุนู„ูŠู‡ ู…ู‡ู…ุงุช ุฌุฏุง๐Ÿ“
๐Ÿ‘2
ู†ู‚ุงุท ู…ู‡ู…ุฉ mcq ๐Ÿ“Œ

โญโ–ซ๏ธbeta bl only used in HF (carvedilol - bisoprolol - metoprolol) ู…ู‡ู…ุฉ

โ–ซ๏ธnitroprusside not used in chronic only acute

โ–ซ๏ธnitrates + hydralazin used together in HF

โ–ซ๏ธACEI prevent myocardial hypertrophy & remodeling & lower BP w/o reflex tachy

โ–ซ๏ธcaptopril contain SH + rapid onset + short duration

โ–ซ๏ธACEI used in early MI with aspirin + fibrinolytics + beta bl


โญโ–ซ๏ธACEI CI with bilateral renal artery stenosis (ู…ู‡ู…ุฉ) Explain
b/c GFR is maintained by VC of the efferent arteriole by AgII

โ”because they โ†“ Ang-II โ†’ โ†“ VC of the efferent arterioles โ†’ โ†“ GFP and โ†“ GFR โ†’lead to aggravation of renal failure in both kidneys and hyperkalemia

โ–ซ๏ธdiuretics give for fluid control โ†’ โ†“pulmonary congestion + โ†“peripheral ankle edema

โญโ–ซ๏ธdiuretics 1st choice in refractory pulmonary edema

โญโ–ซ๏ธdrugs that lower mortality: (ACEl ARBs - beta bl - spironolactone)

โ–ซ๏ธdigoxin inhibits Na/K ATPase

โ–ซ๏ธdigoxin increase contractility

โ–ซ๏ธdigoxin can cause arrhythmia

โ–ซ๏ธdigoxin cause vagal stim. at (therapeutic dose) & sympathetic stim. at (toxic dose)

โญโ–ซ๏ธit inhibits SAN โ†’โ†“HR (indicate optimal digitalization) + AVN block and increase ERP (ู…ู‡ู…ุฉ)

โญโ–ซ๏ธdigoxin drug of choice for HF + AF

โ–ซ๏ธit has narrow safety margin and give yellow green coloured vision

โญโ–ซ๏ธdigibind is first choice for TTT of digitalis toxicity

โ–ซ๏ธdopamine given in AHF + cardiogenic shock

โ–ซ๏ธMilrinone - Inamrinone are inodilators inhibit phosphodiesterase III

โญโ–ซ๏ธSacubitril-Valsartan are inhibitor of neprilysin enzyme

โญโ–ซ๏ธIvabradine TTT stable angina + CHF with ejection fraction less than 35%
โ–ซ๏ธit selectively inhibit hyperpolar. of cyclic nucleotide channel (funny channels) on SAN
โค2
ุงู„ุญู‚ ุตุงุฑู„ูŠ ุดูˆูŠุฉ ุฅุญุจุงุท ู…ู† ุฃุฎุจุงุฑ ุงู„ูŠูˆู… ุจุณ ุญู†ุฒู„ ุงู„ุจุงู‚ูŠ ุจูŠุด ู†ุณุชููŠุฏูˆุง ูƒู„ู†ุง~
ู†ุนุฑูุด ู†ู‚ูˆู„ ูƒู„ุงู… ู…ุญูุฒ ๐Ÿ˜‚ ุจุณ ู†ุฏูŠุฑูˆุง ุงู„ู„ูŠ ุนู„ูŠู†ุง ูˆ ุงู† ุดุงุก ุงู„ู„ู‡ ุงู„ุชุนุจ ู…ุด ุญูŠุนุฏูŠ ุนุงู„ูุงุถูŠ ู†ุชูˆูƒู„ูˆุง ุนู„ู‰ ุงู„ู„ู‡ ุจุณ ูˆ ูƒู„ู†ุง ู†ุทู„ุนูˆุง ู…ู†ู‡ุง ุฑุงุถูŠูŠู†~ ๐Ÿค

ู†ุจุฏูˆุง ุจุงู„ 4) drugs used in arrhythmia ๐Ÿ’ซ
โค4๐Ÿ‘2
ุฃูˆู„ ุดูŠุก ุงู„ุฏูƒุชูˆุฑุฉ ู‚ุงู„ุช ุงู† ุงู„ุฌุฒุฆูŠุฉ ู‡ุฏูŠ ู…ุชู‚ุฏู…ุฉ ูˆุงุฌุฏ ุจุงู„ู†ุณุจุฉ ู„ุซุงู„ุซุฉ ูู†ุงุฎุฏูˆุง ุนู„ูŠู‡ ู†ู‚ุงุท ู…ุนูŠู†ุฉ ู†ุฑูƒุฒูˆุง ุนู„ูŠู‡ุง~
Audio
AudioLab
ู‡ุฏูŠ ุจุฏุงูŠุฉ ุชุณุฌูŠู„ ุงู„ู…ุญุงุถุฑุฉ ู‚ุงู„ุช ุดู† ุงู„ู…ู‡ู… ูˆ ุดุฑุญุช ุจุงุซูˆูุณูŠูˆู„ูˆุฌูŠ ุจูŠุด ู†ูู‡ู…ูˆุง ุงู„ drugs